VANUCIZUMAB

UNII:	B800Z06O8K
Formula:
Preferred Substance Name:	VANUCIZUMAB

1448221-05-3
BISPECIFIC HUMAN ANTI-ANG-2/ANTI-VEGF-A ANTIBODY
BISPECIFIC HUMAN ANTI-ANG-2/ANTI-VEGF-A MONOCLONAL ANTIBODY
C0U97738AE
IMMUNOGLOBULIN RECOMBINED G1-KAPPA/LAMBDA, ANTI-(HOMO SAPIENS ANGPT2 (ANGIOPOIETIN 2, ANG2))/ANTI-HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)), HUMANIZED MONOCLONAL ANTIBODY
RG7221
RG-7221
RO5520985
RO-5520985
VANUCIZUMAB [INN]
VANUCIZUMAB [USAN]
VANUCIZUMAB [WHO-DD]

Common Chemistry
i
Inxight Drugs
i
GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VANUCIZUMAB

Synonyms and Mappings

Resources